Related Experiment Video
Updated: Mar 19, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Natural and Structure-based RXR Ligand Scaffolds and Their Functions
Marta Dominguez, Susana Alvarez, Angel R de Lera1
1Departamento de Química Orgánica, Facultade de Química, CINBIO and IBIV, Universidade de Vigo, Campus As Lagoas-Marcosende, 36310 Vigo, Spain.
Retinoid X receptors (RXRs) form partnerships influencing gene networks. Rexinoids, RXR modulators, show therapeutic promise for cancer and metabolic diseases, though predicting their precise physiological effects remains challenging.
Area of Science:
- Molecular Endocrinology
- Structural Biology
- Drug Discovery
Background:
- Retinoid X receptors (RXRs) are nuclear receptors that form heterodimers with various partners, modulating gene expression.
- RXRs play crucial roles in cellular processes, including nutrient metabolism, and are implicated in diseases like cancer and metabolic disorders.
- Ligands for RXRs, known as rexinoids, can act as agonists, partial agonists, inverse agonists, or antagonists, influencing RXR function.
Purpose of the Study:
- To explore the therapeutic potential of RXR modulators (rexinoids) in treating diseases such as cancer and metabolic disorders.
- To understand how the structural diversity of rexinoids influences their interaction with RXR and co-regulators.
- To investigate the challenges in predicting the correlation between rexinoid structure and physiological response, especially for heterodimer-selective compounds.
Main Methods:
- Review of existing literature on RXR structure-function relationships and rexinoid design.
- Analysis of ligand-receptor complex structures determined by X-ray crystallography and molecular modeling.
- Examination of the cell and context-dependent interactions of RXR-ligand complexes with co-regulators.
Main Results:
- Rexinoids modulate RXR activity, impacting gene networks involved in metabolism and disease.
- A rexinoid, bexarotene, is clinically approved for cutaneous T-cell lymphoma, demonstrating therapeutic viability.
- Rational drug design, based on structural information, has yielded diverse rexinoids, but predicting physiological outcomes remains complex.
Conclusions:
- RXR modulators offer significant therapeutic potential for a range of diseases.
- Understanding the structural basis of RXR modulation is advancing, but predicting specific physiological responses requires further research.
- Further investigation into rexinoid structure-activity relationships is crucial for optimizing therapeutic applications, particularly for selective rexinoids.
More Related Videos
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites

